Current Genomics in Cardiovascular Medicine

Current Status of Publications of Cardiovascular Interventions in Iran; a PubMed-Based Study

The Future of Genetics and Genomics

In this forward-facing review, we briefly summarize what we see as the state of modern cardiovascular genetics and genomics before outlining some of the key areas in which we believe there is a need for investment if we are to realize the full clinical potential of the field. There is clearly substantial overlap with the field of precision medicine, yet it may be in understanding where genetics...

Blood and cardiovascular disease: the promise and limitations of gene expression analysis.

Developments in the fields of genomics, transcriptomics, and proteomics have modified the definition of complex diseases in recent years. To have increasingly precise protein, genomic, and gene expression signatures would further define disease, advance treatment, and enhance the field of personalized medicine. In the area of cardiovascular disease, these specific areas have not followed parall...

AN OVERVIEW OF STEM CELL AND REGENERATIVE MEDICINE RESEARCHES IN IRAN

Background: In many years, finding modern and appropriate treatments for diseases, especially chronic diseases (such as chronic metabolic diseases) have been one of the most important issues. On the other hand, limitations related to organ transplantation have made a serious need for advanced therapeutic strategies. In this respect, researchers have recognized the benefits of stem cells as a su...

Impact of biomarkers, proteomics, and genomics in cardiovascular disease.

This special issue of Clinical Chemistry provides a comprehensive perspective into the current and future impact of biomarkers, proteomics, and genomics in cardiovascular disease. The growth in both the clinical use and new investigations of biomarkers, whether proteomic or genomic, has been explosive over the past 10 years. Protein biomarkers have been anchored by interdisciplinary guidelines ...